OpenAlex
PricingAboutJobs
Log inGet started
Work

A phase II study of modified FOLFIRINOX for chemotherapy-naïve patients with metastatic pancreatic cancer

HTML

Year: 2018
Type: article
Study design: Clinical Trial
Source: Cancer Chemotherapy and Pharmacology
DOI: 10.1007/s00280-018-3577-9
Authors: Masato Ozaka, Hiroshi Ishii, Tosiya Sato, Makoto Ueno, Masafumi Ikeda, Kazuhiro Uesugi, Naohiro Sata, Kouichirou Miyashita, Nobumasa Mizuno, Kunihiro Tsuji, Takuji Okusaka, Junji Furuse
Institutions: The Cancer Institute Hospital, Japanese Foundation For Cancer Research, Shikoku Cancer Center, Kyoto University, Kanagawa Cancer Center, National Cancer Center Hospital East, Jichi Medical University, SHOWA Medical University Northern Yokohama Hospital, Aichi Cancer Center, Aichi Cancer Center Hospital, Ishikawa Prefectural Central Hospital, National Cancer Center Hospital, Kyorin University
Language: English

Topic: Pancreatic and Hepatic Oncology Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: modified FOLFIRINOX, metastatic pancreatic cancer, chemotherapy-naive patients, 5-fluorouracil, irinotecan, oxaliplatin, gemcitabine, neutropenia, overall survival, progression-free survival, adverse events, interstitial lung disease
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2481516632
FWCI: 5.897
Cites: 12
Cited by: 167
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms